Not that anyone needs my opinion, but I'll throw i

Not that anyone needs my opinion, but I'll throw it in the coffer and let the admins sort it out.

1. Based on my listening to 2 years of conference calls, I think NP is a big risk taker. His bet the monotherapy would work when the other scientists said no emboldened him to value his own advice over their's. Kinda like us OTC investors we get a win and think we got it all figured out and gamble on the next otc when the odds tell you it ain't gonna happen, you don't care because you did it before so you're a genius right? I think and hope the current short term "losses" have humbled NP a bit in this area.
2. Shorts cannot force the price of a stock to go down. They can lie, they can bash, they can borrow and bet it goes down. Mgmt needs to give people a reason to buy. No EUA, cso gone and everything still in the future is the same thing we've been hearing almost 2 years after the vyera deal. If you want to blame the people shorting the stock be my guest. If mgmt gives us revenue those people will learn a valuable lesson. If the status quo remains the next few months, the shorts made a good decision the price will continue to drop.

Worth what you paid for.